相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis
Hui Han et al.
NATURE COMMUNICATIONS (2022)
Prognostic role of METTL1 in glioma
Lun Li et al.
CANCER CELL INTERNATIONAL (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
METTL1-m7G-EGFR/EFEMP1 axis promotes the bladder cancer development
Xiaoling Ying et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Cisplatin nanoparticles possess stronger anti-tumor synergy with PD1/PD-L1 inhibitors than the parental drug
Na Shen et al.
ACTA BIOMATERIALIA (2021)
m7GHub: deciphering the location, regulation and pathogenesis of internal mRNA N7-methylguanosine (m7G) sites in human
Bowen Song et al.
BIOINFORMATICS (2020)
Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
Emilie Picard et al.
FRONTIERS IN IMMUNOLOGY (2020)
WBSCR22 confers cell survival and predicts poor prognosis in glioma
Yajie Chi et al.
BRAIN RESEARCH BULLETIN (2020)
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer
Anqi Lin et al.
FRONTIERS IN IMMUNOLOGY (2020)
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
T. Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
Immunotherapy in colorectal cancer: rationale, challenges and potential
Karuna Ganesh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
m6Acomet: large-scale functional prediction of individual m6A RNA methylation sites from an RNA co-methylation network
Xiangyu Wu et al.
BMC BIOINFORMATICS (2019)
Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
Sally Temraz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN
Qiu-Hong Tian et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma
Chuanjie Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Overexpressed methvItransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR149-3p/S100A4/p53 axis
Yang Liu et al.
AGING-US (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Titin mutation associated with responsiveness to checkpoint blockades in solid tumors
Qingzhu Jia et al.
JCI INSIGHT (2019)
MODOMICS: a database of RNA modification pathways. 2017 update
Pietro Boccaletto et al.
NUCLEIC ACIDS RESEARCH (2018)
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer
Xiangchun Li et al.
JAMA ONCOLOGY (2018)
7-Methylguanosine Modifications in Transfer RNA (tRNA)
Chie Tomikawa
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
Qingzhu Jia et al.
NATURE COMMUNICATIONS (2018)
Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Zhong-Yi Dong et al.
CLINICAL CANCER RESEARCH (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Mizuki Nishino et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Colorectal cancer statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Time-dependent ROC curve analysis in medical research: current methods and applications
Adina Najwa Kamarudin et al.
BMC MEDICAL RESEARCH METHODOLOGY (2017)
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)
K. Yamazaki et al.
ANNALS OF ONCOLOGY (2016)
The evolving role. of microsatellite instability in colorectal cancer: A review
Fabio Gelsomino et al.
CANCER TREATMENT REVIEWS (2016)
Microsatellite Instability as a Biomarker for PD-1 Blockade
Jonathan C. Dudley et al.
CLINICAL CANCER RESEARCH (2016)
mRNA capping: biological functions and applications
Anand Ramanathan et al.
NUCLEIC ACIDS RESEARCH (2016)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
Chiara Cremolini et al.
LANCET ONCOLOGY (2015)
Nomograms in oncology: more than meets the eye
Vinod P. Balachandran et al.
LANCET ONCOLOGY (2015)
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
T. Gruenberger et al.
ANNALS OF ONCOLOGY (2015)
eIF4E3, a new actor in mRNA metabolism and tumor suppression
Laurent Volpon et al.
CELL CYCLE (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition
Michael J. Osborne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Macrophages Good guys in colorectal cancer
Sofia Edin et al.
ONCOIMMUNOLOGY (2013)
Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases
R. P. Jones et al.
BRITISH JOURNAL OF SURGERY (2012)
Identification of Gemin5 as a Novel 7-Methylguanosine Cap-Binding Protein
Shelton S. Bradrick et al.
PLOS ONE (2009)
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
M Olivier et al.
CLINICAL CANCER RESEARCH (2006)
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies
Antonio Russo et al.
ANNALS OF ONCOLOGY (2005)
P53 and prognosis: New insights and further complexity
KH Vousden et al.
CELL (2005)
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor
LB Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging
JB O'Connell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
分享论文
